Recombinant Human BMPR-II Protein(HEK293), C-hFc;C-His

BMPR-II (Bone Morphogenetic Protein Receptor Type II) is a crucial transmembrane receptor that plays a significant role in the bone morphogenetic protein (BMP) signaling pathway, which is essential for various biological processes, including embryonic development, tissue homeostasis, and bone formation. Mutations or dysfunctions in the BMPR-II gene are linked to serious cardiovascular conditions, particularly heritable pulmonary arterial hypertension (PAH), where abnormal vascular remodeling leads to increased pulmonary artery pressure and associated morbidity. Research into BMPR-II recombinant protein focuses on understanding its structural and functional properties, exploring its role in cellular signaling, and its potential therapeutic applications. Recombinant BMPR-II is being investigated for its ability to restore or mimic endogenous BMPR-II signaling in pathological conditions, offering insights into novel treatment strategies for PAH and other diseases linked to disrupted BMP signaling. Additionally, studies on BMPR-II’s interactions with various ligands and downstream signaling molecules aim to elucidate its mechanism of action, thereby contributing to the development of targeted therapies that could mitigate the effects of BMPR-II deficiencies. As such, BMPR-II recombinant protein serves as a valuable tool in both basic and clinical research, holding promise for advancing our understanding of BMP-related pathways and devising innovative approaches for treating related disorders.